AR205388A1 - Procedimiento para la preparacion de nuevo derivado de amino-3 hidroxi-2 fenoxi-1 propano sustituido - Google Patents

Procedimiento para la preparacion de nuevo derivado de amino-3 hidroxi-2 fenoxi-1 propano sustituido

Info

Publication number
AR205388A1
AR205388A1 AR259407A AR25940775A AR205388A1 AR 205388 A1 AR205388 A1 AR 205388A1 AR 259407 A AR259407 A AR 259407A AR 25940775 A AR25940775 A AR 25940775A AR 205388 A1 AR205388 A1 AR 205388A1
Authority
AR
Argentina
Prior art keywords
phenoxy
propane
substitute
hydroxy
amino
Prior art date
Application number
AR259407A
Other languages
English (en)
Spanish (es)
Original Assignee
Cm Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cm Ind filed Critical Cm Ind
Application granted granted Critical
Publication of AR205388A1 publication Critical patent/AR205388A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR259407A 1974-06-28 1975-01-01 Procedimiento para la preparacion de nuevo derivado de amino-3 hidroxi-2 fenoxi-1 propano sustituido AR205388A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB28925/74A GB1501632A (en) 1974-06-28 1974-06-28 Aromatic ketones having cardiovascular activity

Publications (1)

Publication Number Publication Date
AR205388A1 true AR205388A1 (es) 1976-04-30

Family

ID=10283421

Family Applications (1)

Application Number Title Priority Date Filing Date
AR259407A AR205388A1 (es) 1974-06-28 1975-01-01 Procedimiento para la preparacion de nuevo derivado de amino-3 hidroxi-2 fenoxi-1 propano sustituido

Country Status (17)

Country Link
US (2) US4252825A (de)
JP (2) JPS5826743B2 (de)
AR (1) AR205388A1 (de)
AT (1) AT343098B (de)
BE (1) BE830766A (de)
CA (1) CA1052820A (de)
CS (1) CS197248B2 (de)
DE (1) DE2528147A1 (de)
DK (1) DK143555C (de)
ES (1) ES438931A1 (de)
FR (1) FR2276032A1 (de)
GB (1) GB1501632A (de)
IE (1) IE41386B1 (de)
NL (1) NL7507703A (de)
SE (2) SE416546B (de)
YU (1) YU165775A (de)
ZA (1) ZA754141B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1501632A (en) * 1974-06-28 1978-02-22 Cm Ind Aromatic ketones having cardiovascular activity
JPH0516363Y2 (de) * 1986-08-01 1993-04-28
GEP20074134B (en) 2002-08-19 2007-06-25 Pfizer Prod Inc Combination therapy for hyperproliferative diseases
NZ543741A (en) * 2003-05-30 2009-10-30 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-Co inhibitors
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
GT200600381A (es) 2005-08-25 2007-03-28 Compuestos organicos
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US8026377B2 (en) * 2005-11-08 2011-09-27 Ranbaxy Laboratories, Limited Process for (3R, 5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-[(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid hemi calcium salt
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
WO2008010087A2 (en) * 2006-07-14 2008-01-24 Ranbaxy Laboratories Limited Polymorphic forms of an hmg-coa reductase inhibitor and uses thereof
ATE547394T1 (de) 2006-12-01 2012-03-15 Bristol Myers Squibb Co N-((3-benzyl)-2,2-(bis-phenyl)-propan-1- aminderivate als cetp-hemmer für die behandlung von atherosklerose und herz-kreislauf- erkrankungen
SG11201507496UA (en) 2013-04-17 2015-11-27 Pfizer N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
SG11202107614PA (en) 2019-01-18 2021-08-30 Astrazeneca Ab Pcsk9 inhibitors and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301580A (de) * 1962-12-11
DE1493454C3 (de) * 1963-08-26 1980-04-30 C.H. Boehringer Sohn, 6507 Ingelheim 1 -Aryloxy^-hydroxy-S-isopropylaminopropane und deren Salze sowie deren Herstellung und darauf basierende Arzneimittel
US3637852A (en) * 1963-08-26 1972-01-25 Boehringer Sohn Ingelheim 1-phenoxy-2-hydroxy-3-isopropylamino-propanes and salts thereof
GB1231783A (en) * 1967-05-16 1971-05-12 May & Baker Ltd Benzene derivatives
JPS512115B2 (de) * 1971-09-28 1976-01-23
JPS4911847A (de) * 1972-05-20 1974-02-01
GB1501632A (en) * 1974-06-28 1978-02-22 Cm Ind Aromatic ketones having cardiovascular activity

Also Published As

Publication number Publication date
JPS5929574B2 (ja) 1984-07-21
JPS5123233A (en) 1976-02-24
AU8256675A (en) 1977-01-06
GB1501632A (en) 1978-02-22
ATA497275A (de) 1977-09-15
IE41386B1 (en) 1979-12-19
AT343098B (de) 1978-05-10
DE2528147A1 (de) 1976-01-15
ES438931A1 (es) 1977-05-16
US4302601A (en) 1981-11-24
NL7507703A (nl) 1975-12-30
SE417087B (sv) 1981-02-23
SE7507359L (sv) 1975-12-29
US4252825A (en) 1981-02-24
DK143555C (da) 1982-02-01
CS197248B2 (en) 1980-04-30
DK143555B (da) 1981-09-07
CA1052820A (en) 1979-04-17
SE416546B (sv) 1981-01-19
YU165775A (en) 1982-02-28
FR2276032A1 (fr) 1976-01-23
BE830766A (fr) 1975-12-29
JPS5826743B2 (ja) 1983-06-04
IE41386L (en) 1975-12-28
SE7812646L (sv) 1978-12-08
DK292475A (da) 1975-12-29
ZA754141B (en) 1976-06-30
JPS58140050A (ja) 1983-08-19
FR2276032B1 (de) 1979-08-10

Similar Documents

Publication Publication Date Title
AR215930A1 (es) Procedimiento para la preparacion de compuestos 2-fenil-3-benzoil-benzotiofeno
AR205388A1 (es) Procedimiento para la preparacion de nuevo derivado de amino-3 hidroxi-2 fenoxi-1 propano sustituido
SE422795B (sv) Forfarande for framstellning av basiskt substituerade naftalen-, kroman-eller kromderivat
AR207869A1 (es) Procedimiento para la produccion de nuevos derivados de 2-(4-alquil-1-piperacinil)-metil-1-bencil-benzimidazol
SE420614B (sv) Forfarande for framstellning av forimpregnerade material
DK554076A (da) Fremgangsmade til fremstilling af 3,4i-dideoxykanamycin ]
MX3635E (es) Procedimiento para la produccion de compuestos de 3-aciloximetilcefem
MX143639A (es) Procedimiento para la preparacion de compuestos disazoicos tetrarreactivos
SE420499B (sv) Forfarande for framstellning av forimpregnerade material
DK143757C (da) Analogifremgangsmaade til fremstilling af 16,16-disubstituerede 3-oxoandrostener
DK148302C (da) Analogifremgangsmaade til fremstilling af 1,3-dialkylxanthinderivater
DK31578A (da) Fremgangsmaade til fremstilling af benzenderivater
SE7601605L (sv) Forfarande for framstellning av 1 alfa,25-dihydroxi-cholkalciferol
AR222003A1 (es) Procedimiento para la preparacion de derivados de fenilpiperazina
DK145470C (da) Fremgangsmaade til fremstilling af et moenstret,biaksialt orienteret,ikke-vaevet stof
MX4134E (es) Procedimiento para la preparacion de los compuestos 1,3-benzoditiol-2-tiona
AR211274A1 (es) Procendimiento para preparar nuevaos compuestos de 2,4-diamono5-(3,5-dihalo-4-aminobencilo)-primidina
SE7600847L (sv) Nytt forfarande for framstellning av 8-bromtienotriazolo-1,4-diazepiner
AR215869A1 (es) Procedimiento para la preparacion de nuevos derivados de 1-fenil-2-aminoetanol
MX5827E (es) Procedimiento para preparar el carbanion de la papaverina
AR214305A1 (es) Procedimiento para la produccion de n-acetiltienamicina
AR208532A1 (es) Un procedimiento para la preparacion de derivados de 3,4,6-tri-0-alcanoilo inferior-2-deoxi-2-nicotinamido-1-0-nicotinoil-glucopiranosa
AR210905A1 (es) Procedimiento de preparacion de 2,4-diamino-5-bencil-pirimidinas
AR208736A1 (es) Procedimiento para la preparacion de un nuevo derivado de la ceafalosporina
AR219282A1 (es) Procedimiento para la preparacion de nuevos compuestos derivados de malonato de pentaclorofenilo